Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Enveric Biosciences Inc
ENVB | US
5.04
USD1.02
25.37%
ENVB | US
Loading StockChartView...
About Enveric Biosciences Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
5.04
Open
4.07
High
7.88
Low
4.04
Enveric Biosciences Inc. a biotechnology company engages in the development of small-molecule therapeutics for the treatment of anxiety depression and addiction disorders. Its lead program is EB-373 an active metabolite of psilocybin which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences Inc. is headquartered in Naples Florida.
View LessENVB | US
Risk
367.2
Sharpe
-0.42
Luna's Score
46/100
Recommendation
Hold
Luna says (ENVB | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
508.4%1 month
367.2%3 months
232.8%6 months
225.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
23.09
Price to book
0.73
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.29
Ent. to rev.
1.76
PEG
-
Other Fundamentals
EBITDA
-9.87M
MarketCap
44.96M
MarketCap(USD)
44.96M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-7.30
Ret. on equity
-206.10
Short ratio
1.86
Short perc.
2.25
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
6.17
Range1M
6.17
Range3M
6.17
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
4.15
Price X volume
209.88M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.29 | 0.53 | Cheaper |
| Ent. to Revenue | 1.76 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.73 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 232.84 | 72.80 | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 44.96M | 3.66B | Emerging |
